Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.800
-0.040 (-0.83%)
Apr 29, 2026, 10:59 AM EDT - Market open

Bolt Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-33.38-63.12-69.2-88.1-98.59
Upgrade
Depreciation & Amortization
1.291.781.851.671.19
Upgrade
Loss (Gain) From Sale of Assets
-0.29-0.07--0.11
Upgrade
Asset Writedown & Restructuring Costs
-1.47---
Upgrade
Loss (Gain) From Sale of Investments
-0.67-2.62-4.490.182.65
Upgrade
Stock-Based Compensation
2.787.419.229.588.5
Upgrade
Other Operating Activities
2.532.32.953.238.56
Upgrade
Change in Accounts Payable
-5.43-4.88-3.412.776.68
Upgrade
Change in Unearned Revenue
-4.64-4.67-3.61-2.1615.57
Upgrade
Change in Other Net Operating Assets
-2.041.12-2.85-3.66-1.74
Upgrade
Operating Cash Flow
-39.85-61.29-69.53-76.5-57.07
Upgrade
Capital Expenditures
-0.07-0.04-0.21-1.95-2.34
Upgrade
Sale of Property, Plant & Equipment
0.960.15---
Upgrade
Investment in Securities
43.4157.4771.2459.82-229.86
Upgrade
Investing Cash Flow
44.357.5871.0457.86-232.2
Upgrade
Issuance of Common Stock
0.020.110.250.5259.21
Upgrade
Financing Cash Flow
0.020.110.250.5311.11
Upgrade
Net Cash Flow
4.47-3.611.77-18.1421.84
Upgrade
Free Cash Flow
-39.92-61.33-69.73-78.46-59.4
Upgrade
Free Cash Flow Margin
-518.80%-797.53%-885.36%-1369.47%-4714.60%
Upgrade
Free Cash Flow Per Share
-21.35-32.12-36.88-42.00-35.79
Upgrade
Levered Free Cash Flow
-24.9-37.54-39.47-46.18-41.99
Upgrade
Unlevered Free Cash Flow
-24.9-37.54-39.47-46.18-41.99
Upgrade
Change in Working Capital
-12.12-8.44-9.86-3.0620.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.